IL1B and central nervous system cancer: The natural IL1 receptor antagonist IL1RA exhibits neuroprotective and anti-inflammatory properties, and it can promote the growth of glioma by blocking the inhibitory effect of IL-1 on the proliferation of glioma cells [65–68].